Form 4: Xtant Medical Holdings Director, Lori D. Mitchell-Keller, Reports Stock Transactions

Lori D. Mitchell-Keller, a director of Xtant Medical Holdings, reported the acquisition of 162,162 shares and the disposal of an unquantified amount of common stock on August 15, 2024.

Summary

• On August 15, 2024, Lori D. Mitchell-Keller, a director of Xtant Medical Holdings, Inc., reported transactions involving the company's common stock.
• Mitchell-Keller acquired 162,162 shares of common stock.
• These shares are related to a restricted stock unit (RSU) award granted under the company's 2023 Equity Incentive Plan.
• The shares vest and become issuable on August 15, 2025, contingent upon Mitchell-Keller remaining a director through the vesting date.
• Mitchell-Keller also disposed of an unquantified amount of common stock.
• Following the reported transactions, Mitchell-Keller beneficially owns 353,124 shares, which includes the 162,162 shares to be issued upon vesting of the RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The RSU grant is a positive sign of aligning director interests, but the disposal of shares is a slightly negative signal.

Positives

• The grant of restricted stock units to a director aligns their interests with the long-term performance of the company.
• The vesting condition encourages continued service and commitment from the director.

Negatives

• The document does not specify the exact amount of common stock disposed of by Mitchell-Keller.

Risks

• The vesting of the restricted stock units is contingent upon the director remaining in their position, which introduces a risk if the director were to leave the company before the vesting date.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting of the restricted stock units in August 2025.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign of aligning director interests with company performance.
• The transactions provide transparency into the director's holdings and activities.

Key Dates